In vitro diagnostic solution for rapid COVID-19 detection. Provides point-of-care testing capabilities for viral identification.
Manufactured by
Lansion Biotechnology Co., Ltd.
Nanjing, China
Lansion Biotechnology Co., Ltd.(Lansionbio) was established in Nanjing, China in 2016. As one high-tech enterprise and key technology-based enterprise, Lansionbio is committed to the research development, production, sales and service of in vitro diagnostic reagents and devices. Through the integrated multi-platform POCT workstation, it provides medical units and families with comprehensive solutions for on-site rapid detection, and has become a representative enterprise of the new generation of laboratory medicine industry ecology in China. Since 2020, Lansionbio has been actively involved in the prevention and control of the global COVID-19 epidemic, and its related products have obtained CE certification and product registration in many countries, and are exported to more than 50 countries and regions outside of China.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
DIA.PRO Diagnostic BioProbes Srl
Italy · 1 relevant product
CerTest Biotec S.L.
Spain · 1 relevant product
LumiQuick Diagnostics, Inc.
United States · 1 relevant product
92 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 115 closest product alternatives
DIA.PRO Diagnostic BioProbes Srl · Italy
A diagnostic testing solution for COVID-19 detection. The company offers PCR-based assays for SARS-CoV-2 detection, with verification against new variants such as Omicron B.1.1.529. Products include RT-PCR assays and ELISA kits for IgM monitoring of immune response in early infection stages.
CerTest Biotec S.L. · Spain
SARS-CoV-2 self-testing kit for rapid, patient-performed detection of COVID-19 infection. This in vitro diagnostic test enables point-of-care screening with simplified procedures suitable for clinical and home settings.
LumiQuick Diagnostics, Inc. · United States
SARS-CoV-2 rapid immunochromatographic assays for qualitative detection of viral infection. Available in multiple formats including test cards, cups, and dip tests for point-of-care testing in clinical and research settings. Designed for quick, accurate diagnosis to support clinical decision-making.
112 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products